Treatment with empagliflozin significantly decreased levels of circulating PRO-C3, reflecting attenuated systemic fibroblast activation, and to what extent this indicated antifibrotic effect may underpin the clinical effects of empagliflozin remains to be elucidated.
J. Jensen, C. Andersen, M. Omar et al.· European Heart Journal· 0 citations
Survivors of all 21 cancer subtypes had a higher associated rate of VTE compared with the background population, with the highest incidence rates found for multiple myeloma.
A. Yafasova, Guo-Li Sun, M. Hutchings et al.· European Journal of Preventi...· 0 citations
Recurrent MI is associated with a higher risk of all-cause mortality, hospitalization for heart failure, HHF, and further recurrent MI compared with first-time MI.
D. M. Christensen, C. Garred, M. Malmborg et al.· American Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.